iPlexus: Blockchain and AI Power for faster and more efficient drug development.


iPlexus – a one stop solution for all relevant information within the pharmaceutical industry. The AI and Blockchain powered discovery engine accelerates your drug discovery and research process. Senior executives get real-time data insights on a fingertip for empowered, inspired & faster decisions.

Get the Data on iPlexus




Clinical Trials


Congress Articles


Drug Profiles




Patient forums and more

Secured enterprise data

Successful and failed experiments

Science cannot wait, when patient lives are at stake.

Current state of preclinical research ecosystem


  • No means to access and share unpublished experimental data
  • No means to access and share data on failed experiments
  • No mechanism to broadcast IP before publishing in peer reviewed journals

How does iPlexus improve it fundamentally?


  • Entire published available life science universe with TBs of data in an ontology based knowledge graph
  • Secured platform to share unpublished data on successful and failed experiments
  • Secured IP as experiment broadcasted with an immutable time stamp – AI based guidance valuation of data

Blockchain and AI based iPlexus overcomes data silos to make drug discovery more efficient


We leverage collective intelligence


Search and access published and

unpublished data based on

concepts, author name etc.


Gain insights on Discovery and

Preclinical landscape without the peer

review blind spot of 18-24 months


Acquire exclusive license to use

other’s work

iPlexus: AI based tool for discovery

iPlexus is an innovative and intuitive semantic discovery platform which understands biomedical concepts and allows you to see relevant results in context across multiple data sources like publications, clinical trials, congresses, theses, patents and much more. All in one place, real-time.


With iPlexus you generate intelligence and insights across pre-clinical, clinical, regulatory and commercial phases of a drug development in a quick, crisp and summarized snapshot with various deep dive opportunities. You can discover most relevant proteins, drugs, diseases, genes and also establish relations between any biomedical entity.  It helps you to make informed and data-backed decisions.




The iPlexus Approach

Holistic view of the landscape

with integrated published +

unpublished as well as enterprise

data in a fully secured way

Competitive advantage through

exclusive licensing of unpublished

data. Authors protect IP as their

experimental meta data is

broadcasted immutably

AI based guidance valuation of

unpublished data. Large training

data starts the AGI1 paradigm

Your benefits from iPlexus

Strengthening the health care system through practical innovation acceleration and equal opportunities

  • Incentives also for smaller researchers to share even failed experimental data
  • Data enrichment to accelerate innovation, taking data protection into account
  • Increased innovation dynamics for the benefit of the patient

Performance-oriented, objective promoting of research work

  • Secured authorship makes it easier to share even unpublished data
  • Increased innovation efficiency and intelligence due to advanced knowledge base
  • Financing by providing self-failed experimental data

Shorter discovery cycles and cost savings for the life science industry

  • Wider knowledge base through insights into unpublished experiments
  • Insights into the current trend of research and development
  • Cost and time savings through acquisition of results of experiments already performed

Want to learn more about iPlexusTM, discovery and blockchain?



We are committed to helping researchers and students from academic institutions experience the power of iPlexus.

With our ACADEMIC version, you can start using iPlexus for free.

Know More
Book a Free Consultation